Reuters logo
BRIEF-PLX Pharma announces pricing of registered direct offering
June 12, 2017 / 11:05 AM / 6 months ago

BRIEF-PLX Pharma announces pricing of registered direct offering

June 12 (Reuters) - Plx Pharma Inc

* PLX Pharma announces pricing of registered direct offering

* To use net proceeds from this offering, together with current cash resources, to advance aspertec 325 mg to market-readiness

* Pricing of registered direct offering of 2.65 million shares of common stock at an offering price per share of $6.875

* Also to use proceeds from offering, together with current cash resources, to fund technology transfer, commercial scale validation, manufacturing Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below